Accendra Health (ACH) Receivables (2009 - 2026)

Accendra Health (ACH) has reported Receivables for 18 consecutive years, with $120.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables fell 38.85% year-over-year to $120.1 million in Q2 2026; TTM through Jun 2026 was $120.1 million, a 38.85% decrease from a year earlier, with the FY2025 full-year figure at $95.9 million, down 56.06% from the prior year.
• Receivables was $120.1 million for Q2 2026 at Accendra Health, up from $103.7 million in the prior quarter.
• Over five years, Receivables peaked at $775.8 million in Q1 2022 and troughed at $95.9 million in Q4 2025.
• A 5-year average of $514.3 million and a median of $662.1 million in 2024 frame the typical range for Receivables.
• Across the five-year window, Receivables gained 12.02% in 2022 and sank 82.13% in 2026, its largest moves.
• Over 5 years, Receivables stood at $763.5 million in 2022, then decreased by 21.64% to $598.3 million in 2023, then plunged by 63.52% to $218.3 million in 2024, then plunged by 56.06% to $95.9 million in 2025, then advanced by 25.21% to $120.1 million in 2026.
• The last three Receivables figures came in at $120.1 million (Q2 2026), $103.7 million (Q1 2026), and $95.9 million (Q4 2025), per Business Quant data.